Clinical expertise, engineering innovation, and commercial execution — built to bring Alsteni from concept to cleared medical device.
Board-certified endocrinologist with 30+ years of clinical and research experience. Inventor of the Alsteni System and principal investigator on all clinical studies. Published in Nutrition & Diabetes and presented at ADA, ENDO, and ObesityWeek.
Former faculty at USC Keck School of Medicine. Dr. Beale's insight that jejunal nutrient delivery could trigger natural satiety hormones — the same mechanism behind gastric bypass outcomes — led to the development of the Alsteni platform.
Leads fundraising, investor relations, commercial strategy, and go-to-market planning. Techstars alumni (USC 2025). Built an investor pipeline of 500+ qualified contacts across VCs, angels, strategic corporates, and international opportunities.
Directs AI-augmented operations enabling capital efficiency equivalent to a 5–10 person team. Manages all external communications, strategic partnerships, and business development.
25+ years in medical device commercialization with a track record of scaling devices from concept through regulatory clearance to market adoption. Extensive network across medtech investors and strategic acquirers.
Oversees manufacturing partnerships, supply chain development, and operational execution. Manages relationships with Medical Murray, APP Medical, and other manufacturing partners.
42 issued patents across medical devices and orthodontics. Former Principal Product Development Engineer at Ormco, where he led development of the Damon System ($150M+ annual revenue). Expert in CAD modeling, finite element analysis, and superelastic materials.
Designed the Gen 1 production device and is developing the Gen 2 flexible connector system with enhanced safety mechanisms. Leads all hardware design, prototyping, and manufacturing engineering.
Managing Director with deep connections across Korean medtech investment and distribution. Leading TIPS program application and strategic partnership development in Asia.
Strategic business advisor providing guidance on corporate structure, growth strategy, and operational optimization for early-stage medical device companies.
Former FDA reviewer with deep expertise in medical device regulatory pathways. Provides strategic guidance on 510(k) submissions, clinical study design, and FDA engagement.
Faculty at Creighton University serving as academic lead for the OASIS-90 clinical trial. Provides IRB infrastructure and faculty oversight for clinical studies.
Health economics and reimbursement specialist developing the coverage strategy for Alsteni Nourish including CPT codes, payer engagement, and site-of-service optimization.
We're building a team of people who believe patients deserve better options. Whether as a clinical partner, advisor, or investor — let's talk.
Get in Touch →